ArticleNeurology and therapy2021

Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study.

Preeya J Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.